Alert: New Earnings Report (8/6/24)-Myriad Genetics Inc (NASDAQ: MYGN).
Myriad Genetics Inc (NASDAQ: MYGN) has reported E.P.S. of $-0.41 for its second fiscal quarter (ending June 30) versus $-1.42 for the same period a year ago. Relative to the consensus estimate of $-0.01, this […]